Azienda Ulss 5 Polesana
- Address
- Viale Tre Martiri 89, Sarzano, 45100 Rovigo, Italy
Azienda Ulss 5 Polesana - Advanced Oncology and Cardiovascular Research
Azienda Ulss 5 Polesana is a clinical research center actively engaged in investigating innovative therapeutic approaches for life-threatening conditions. The center demonstrates particular expertise in cardiovascular emergencies and gynecological oncology, contributing to pivotal international trials that aim to optimize treatment strategies and improve patient outcomes.
- Thrombolytic therapy optimization for intermediate-high-risk acute pulmonary embolism
- PARP inhibitor maintenance therapy in advanced ovarian and peritoneal cancers
- Biomarker-driven personalized treatment approaches in BRCA wild-type tumors
The center's cardiovascular research focuses on acute pulmonary embolism management, specifically evaluating reduced-dose thrombolytic protocols to balance efficacy with safety in intermediate-high-risk patients. In the oncology domain, the center participates in studies exploring Olaparib maintenance therapy for patients with BRCA wild-type advanced ovarian, fallopian tube, and peritoneal cancers, emphasizing the integration of clinical and biological tumor characteristics to predict treatment response and progression-free survival outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Azienda Ulss 5 Polesana
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-Type Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma | IRCCS Istituto Nazionale Tumori Fondazione Pascale | Phase II | Recruiting | Dec 2024 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Alteplase | 1 | Unknown | 2021-08-04 | 2021-08-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.